Clinical Trial Update: Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia [NA]

View source ↗

Summary

The document reports the completion of a clinical trial evaluating donor lymphocyte infusion for relapsed leukemia after transplantation across several myeloid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Donor Lymphocyte Infusion

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Myeloid, Chronic, AML | NA | Status: COMPLETED